Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...
To treat depression, the tech magnate has said he'd rather use ketamine, a dissociative anesthetic, than traditional antidepressants.
The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinctâ„¢ accelerators and ROCmâ„¢ software to power ...
Azafaros B.V. today announced that its lead asset, nizubaglustat, has been granted orphan drug designation from regulatory authorities in both the United States and the European Union for the ...
A newly elected Democrat filed a bill Friday to protect public employees from positive marijuana tests – if they have a ...
Aspiring rapper Kelyan Bokassa was fatally injured on a route 472 bus in Woolwich Church Street, close to the Woolwich Ferry, ...
Next week at the CES 2025 trade show in Las Vegas, we'll once again be able to see and hear about the latest tech trends in person.
Now that weight-loss drugs are in greater demand from both patients and doctors, state Medicaid programs are grappling with ...